• SPX
  • $5,969.34
  • 0.35 %
  • $20.63
  • DJI
  • $44,296.51
  • 0.97 %
  • $426.16
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $19,003.65
  • 0.16 %
  • $31.23
Enliven Therapeutics, Inc. (ELVN) Insider Traders

Enliven Therapeutics, Inc. (ELVN) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price

$24.47

-$0.94

(-3.7%)

Day's range
$24.36
Day's range
$26.09
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    0
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    9
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $0
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $60.73 M

Enliven Therapeutics, Inc. Insider Transactions

Enliven Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
Sell 11,422 @ $21.63 $247,014 1,076,103 06/25/2024 06/27/2024
Sell 578 @ $22.30 $12,887 1,075,525 06/25/2024 06/27/2024
Sell 1,270 @ $21.48 $27,278 134,615 06/17/2024 06/20/2024
Patel Anish

CHIEF OPERATING OFFICER

Sell 1,133 @ $20.06 $22,722 0 06/06/2024 06/10/2024
Lyssikatos Joseph P

Director, CHIEF SCIENTIFIC OFFICER

Sell 9,877 @ $21.56 $212,988 2,123 05/29/2024 05/31/2024
Lyssikatos Joseph P

Director, CHIEF SCIENTIFIC OFFICER

Sell 2,123 @ $22.52 $47,813 0 05/29/2024 05/31/2024
Sell 6,681 @ $22.86 $152,756 5,319 05/28/2024 05/30/2024
Sell 5,219 @ $23.57 $123,020 100 05/28/2024 05/30/2024
Sell 100 @ $24.34 $2,434 0 05/28/2024 05/30/2024
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 1,906 @ $22.89 $43,628 2,344 05/28/2024 05/30/2024
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 2,334 @ $23.42 $54,659 10 05/28/2024 05/30/2024
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 10 @ $24.34 $243 0 05/28/2024 05/30/2024
ORBIMED ADVISORS LLC

Director, 10 percent owner:

Sell 33,300 @ $22.14 $737,262 254,814 05/16/2024 05/20/2024
ORBIMED ADVISORS LLC

Director, 10 percent owner:

Sell 1,000,000 @ $22.14 $22.14 M 7,663,349 05/16/2024 05/20/2024
Gupta Rishi

Director, 10 percent owner:

Sell 1,000,000 @ $22.14 $22.14 M 7,663,349 05/16/2024 05/20/2024
Gupta Rishi

Director, 10 percent owner:

Sell 33,300 @ $22.14 $737,262 254,814 05/16/2024 05/20/2024
Sell 1,270 @ $23.74 $30,150 135,885 05/16/2024 05/20/2024
Patel Anish

CHIEF OPERATING OFFICER

Sell 1,107 @ $25.00 $27,675 0 05/14/2024 05/16/2024
Patel Anish

CHIEF OPERATING OFFICER

Sell 260 @ $25.06 $6,515 0 05/09/2024 05/13/2024
Patel Anish

CHIEF OPERATING OFFICER

Sell 4,875 @ $22.72 $110,769 0 05/06/2024 05/08/2024

Enliven Therapeutics, Inc. Frequently Asked Questions

  • Who is on Enliven Therapeutics, Inc.'s Insider Roster?

    The list of insiders at Enliven Therapeutics, Inc. includes Kintz Samuel, Hohl Benjamin, Ballal Rahul D., Lyssikatos Joseph P, Patel Anish, Collins Helen Louise, Heyman Richard A., Gupta Rishi, ORBIMED ADVISORS LLC.

  • How much insider selling is happening at Enliven Therapeutics, Inc.?

    Insiders have sold a total of 2.68 M Enliven Therapeutics, Inc. shares in the last 12 months for a total of 60.73 M sold.

  • Which Enliven Therapeutics, Inc. insiders have been selling company stock?

    The following insiders have sold Enliven Therapeutics, Inc. shares in the last 12 months: Kintz Samuel ($4.08 M), Hohl Benjamin ($1.70 M), Ballal Rahul D. ($1.99 M), Lyssikatos Joseph P ($4.16 M), Patel Anish ($1.97 M), Collins Helen Louise ($525,960), Heyman Richard A. ($553,674), Gupta Rishi ($22.88 M), ORBIMED ADVISORS LLC ($22.88 M),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.